Microsoft Corporation

NASDAQ Global Select
Bullish +65

Microsoft (MSFT) Stock Rises as Oppenheimer Raises Price Target on Copilot Overhaul

πŸ“ˆ Microsoft stock rose as much as 4% to $516.39 following analyst upgrades and the launch of a revamped Copilot app.

πŸ” Oppenheimer analyst Brian Schwartz raised his price target on MSFT to $570, citing increasing enterprise standardization on Microsoft's AI platform.

πŸ“ˆ Stifel analyst Brad Reback upgraded MSFT from Hold to Buy with a new price target of $575, indicating roughly 11% upside.

πŸ”„ Microsoft merged consumer and workplace Copilot into a single business-focused app, abandoning the personal companion strategy.

πŸ’» The new Copilot features include a home hub for editing Office files, a low-code tool for non-technical staff, and an Autopilot agent for background tasks.

πŸ’° Microsoft introduced a split pricing model with fixed fees for chat and pay-as-you-go billing for agentic tasks.

πŸ“‰ This pricing shift changes revenue predictability by tying part of the income to actual usage rather than just seat counts.

🏒 MSFT maintains over 30 million paid Copilot enterprise subscriptions, providing a steady base before the new billing structure takes effect.

⚠️ Analysts warn of risks including AI disruption and potential forward shifts in enterprise tech spending that could impact growth.

πŸ“Š The stock currently carries a Buy consensus among 55 analysts, with 14 Strong Buys and 38 Buys against three Holds.

Bullish Signals
  • Microsoft stock climbed as much as 4% to $516.39 following positive analyst sentiment and the rollout of a major Copilot app overhaul.
  • Oppenheimer analyst Brian Schwartz raised his price target on MSFT to $570 from $515, maintaining an Outperform rating due to enterprise standardization.
  • Stifel analyst Brad Reback upgraded MSFT from Hold to Buy and increased his price target to $575, projecting roughly 11% upside.
  • Microsoft successfully merged consumer and workplace Copilot into a single business-focused app, streamlining its enterprise AI strategy.
  • The new Copilot suite includes advanced tools like Autopilot for persistent background tasks and low-code capabilities for non-technical staff.
  • MSFT holds over 30 million paid Copilot enterprise subscriptions, establishing a strong foundation for its AI revenue stream.
Risk Factors
  • The shift to usage-based billing for agentic tasks reduces the predictability of Microsoft's AI revenue compared to the previous seat-based model.
Full Analysis
Microsoft (MSFT) shares climbed as much as 4% on Friday, reaching $516.39, driven by a price target increase from Oppenheimer and the rollout of a major overhaul to its Copilot app. Analyst Brian Schwartz raised his price target to $570 from $515 while maintaining an Outperform rating, citing growing customer standardization on Microsoft as their primary enterprise AI platform. Stifel analyst Brad Reback also upgraded his outlook, moving Microsoft from Hold to Buy and raising his price target to $575. This new target suggests approximately 11% upside from Friday's closing price. The broader technology sector supported the rally, with the Technology Select Sector SPDR Fund rising 0.8%, though Microsoft has lagged its own sector significantly for most of 2026. Microsoft merged its consumer and workplace Copilot assistants into a single business-focused app, ending its push for a personal AI companion. The redesigned application centers on three tools: a home hub combining chat with task delegation for Office files, a GitHub Copilot-based tool for non-technical staff to build apps, and an Autagent called Autopilot for persistent background tasks. The company shifted to a split pricing model where everyday chat use carries a fixed subscription fee, while longer agentic tasks are billed on a pay-as-you-go basis. This change alters the predictability of Microsoft's AI revenue, moving away from a purely seat-based model toward usage-based billing for specific agent tools. The company currently holds over 30 million paid Copilot enterprise subscriptions.